Cargando…
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confide...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063589/ https://www.ncbi.nlm.nih.gov/pubmed/33890566 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.16.2100348 |
| _version_ | 1783681976700502016 |
|---|---|
| author | Funk, Tjede Pharris, Anastasia Spiteri, Gianfranco Bundle, Nick Melidou, Angeliki Carr, Michael Gonzalez, Gabriel Garcia-Leon, Alejandro Crispie, Fiona O’Connor, Lois Murphy, Niamh Mossong, Joël Vergison, Anne Wienecke-Baldacchino, Anke K. Abdelrahman, Tamir Riccardo, Flavia Stefanelli, Paola Di Martino, Angela Bella, Antonino Lo Presti, Alessandra Casaca, Pedro Moreno, Joana Borges, Vítor Isidro, Joana Ferreira, Rita Gomes, João Paulo Dotsenko, Liidia Suija, Heleene Epstein, Jevgenia Sadikova, Olga Sepp, Hanna Ikonen, Niina Savolainen-Kopra, Carita Blomqvist, Soile Möttönen, Teemu Helve, Otto Gomes-Dias, Joana Adlhoch, Cornelia |
| author_facet | Funk, Tjede Pharris, Anastasia Spiteri, Gianfranco Bundle, Nick Melidou, Angeliki Carr, Michael Gonzalez, Gabriel Garcia-Leon, Alejandro Crispie, Fiona O’Connor, Lois Murphy, Niamh Mossong, Joël Vergison, Anne Wienecke-Baldacchino, Anke K. Abdelrahman, Tamir Riccardo, Flavia Stefanelli, Paola Di Martino, Angela Bella, Antonino Lo Presti, Alessandra Casaca, Pedro Moreno, Joana Borges, Vítor Isidro, Joana Ferreira, Rita Gomes, João Paulo Dotsenko, Liidia Suija, Heleene Epstein, Jevgenia Sadikova, Olga Sepp, Hanna Ikonen, Niina Savolainen-Kopra, Carita Blomqvist, Soile Möttönen, Teemu Helve, Otto Gomes-Dias, Joana Adlhoch, Cornelia |
| author_sort | Funk, Tjede |
| collection | PubMed |
| description | We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0–2.9; B.1.351: 3.6, 95% CI: 2.1–6.2; P.1: 2.6, 95% CI: 1.4–4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4–3.5; P.1: 2.2, 95% CI: 1.7–2.8). |
| format | Online Article Text |
| id | pubmed-8063589 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Centre for Disease Prevention and Control (ECDC) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80635892021-04-27 Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 Funk, Tjede Pharris, Anastasia Spiteri, Gianfranco Bundle, Nick Melidou, Angeliki Carr, Michael Gonzalez, Gabriel Garcia-Leon, Alejandro Crispie, Fiona O’Connor, Lois Murphy, Niamh Mossong, Joël Vergison, Anne Wienecke-Baldacchino, Anke K. Abdelrahman, Tamir Riccardo, Flavia Stefanelli, Paola Di Martino, Angela Bella, Antonino Lo Presti, Alessandra Casaca, Pedro Moreno, Joana Borges, Vítor Isidro, Joana Ferreira, Rita Gomes, João Paulo Dotsenko, Liidia Suija, Heleene Epstein, Jevgenia Sadikova, Olga Sepp, Hanna Ikonen, Niina Savolainen-Kopra, Carita Blomqvist, Soile Möttönen, Teemu Helve, Otto Gomes-Dias, Joana Adlhoch, Cornelia Euro Surveill Rapid Communication We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0–2.9; B.1.351: 3.6, 95% CI: 2.1–6.2; P.1: 2.6, 95% CI: 1.4–4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4–3.5; P.1: 2.2, 95% CI: 1.7–2.8). European Centre for Disease Prevention and Control (ECDC) 2021-04-22 /pmc/articles/PMC8063589/ /pubmed/33890566 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.16.2100348 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| spellingShingle | Rapid Communication Funk, Tjede Pharris, Anastasia Spiteri, Gianfranco Bundle, Nick Melidou, Angeliki Carr, Michael Gonzalez, Gabriel Garcia-Leon, Alejandro Crispie, Fiona O’Connor, Lois Murphy, Niamh Mossong, Joël Vergison, Anne Wienecke-Baldacchino, Anke K. Abdelrahman, Tamir Riccardo, Flavia Stefanelli, Paola Di Martino, Angela Bella, Antonino Lo Presti, Alessandra Casaca, Pedro Moreno, Joana Borges, Vítor Isidro, Joana Ferreira, Rita Gomes, João Paulo Dotsenko, Liidia Suija, Heleene Epstein, Jevgenia Sadikova, Olga Sepp, Hanna Ikonen, Niina Savolainen-Kopra, Carita Blomqvist, Soile Möttönen, Teemu Helve, Otto Gomes-Dias, Joana Adlhoch, Cornelia Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 |
| title | Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 |
| title_full | Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 |
| title_fullStr | Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 |
| title_full_unstemmed | Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 |
| title_short | Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 |
| title_sort | characteristics of sars-cov-2 variants of concern b.1.1.7, b.1.351 or p.1: data from seven eu/eea countries, weeks 38/2020 to 10/2021 |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063589/ https://www.ncbi.nlm.nih.gov/pubmed/33890566 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.16.2100348 |
| work_keys_str_mv | AT funktjede characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT pharrisanastasia characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT spiterigianfranco characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT bundlenick characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT melidouangeliki characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT carrmichael characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT gonzalezgabriel characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT garcialeonalejandro characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT crispiefiona characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT oconnorlois characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT murphyniamh characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT mossongjoel characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT vergisonanne characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT wieneckebaldacchinoankek characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT abdelrahmantamir characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT riccardoflavia characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT stefanellipaola characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT dimartinoangela characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT bellaantonino characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT loprestialessandra characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT casacapedro characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT morenojoana characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT borgesvitor characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT isidrojoana characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT ferreirarita characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT gomesjoaopaulo characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT dotsenkoliidia characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT suijaheleene characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT epsteinjevgenia characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT sadikovaolga characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT sepphanna characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT ikonenniina characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT savolainenkopracarita characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT blomqvistsoile characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT mottonenteemu characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT helveotto characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT gomesdiasjoana characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT adlhochcornelia characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 AT characteristicsofsarscov2variantsofconcernb117b1351orp1datafromseveneueeacountriesweeks382020to102021 |